Joincare Pharmaceutical Group Industry Co Ltd 2023 SR

The report highlights Joincare's commitment to "innovative medicines + high-barrier complex formulations," focusing on respiratory, gastroenterology, and other key therapeutic areas. In 2023, the company achieved an MSCI ESG rating of "AA" and successfully included its independently developed Tobramycin Inhalation Solution in China's National Reimbursement Drug List. Joincare made significant strides in environmental management, publishing its Climate Change Management System with targets for carbon peaking by 2028 and neutrality by 2055. Socially, the company continued its "Access to Public Welfare for Chronic Diseases Prevention and Treatment Programme," benefiting over 19,000 patients, and donated RMB 20 million for earthquake relief in Gansu.

Company: Joincare Pharmaceutical Group Industry Co Ltd

Sector: Health Care

Country: China

Year: 2023

Type: SR

Pages: 133

Back to company

Joincare Pharmaceutical Group Industry Co Ltd

Joincare Pharmaceutical Group Industry Co Ltd 2023 Social Responsibility Report

Social Responsibility Report

The report highlights Joincare's commitment to "innovative medicines + high-barrier complex formulations," focusing on respiratory, gastroenterology, and other key therapeutic areas. In 2023, the company achieved an MSCI ESG rating of "AA" and successfully included its independently developed Tobramycin Inhalation Solution in China's National Reimbursement Drug List. Joincare made significant strides in environmental management, publishing its Climate Change Management System with targets for carbon peaking by 2028 and neutrality by 2055. Socially, the company continued its "Access to Public Welfare for Chronic Diseases Prevention and Treatment Programme," benefiting over 19,000 patients, and donated RMB 20 million for earthquake relief in Gansu.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2023

Reporting Period

Jan 1, 2023 - Dec 31, 2023

Fiscal Year

2023

Type

Sustainability Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Renewable Energy

Water Consumption

Total Waste

Women on Board

Women in Management

Workplace Fatalities

Net Zero Target

Employees